T. Rowe Price Associates’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $290M | Buy |
3,461,482
+1,061,064
| +44% | +$88.9M | 0.03% | 360 |
|
|
2025
Q1 | $172M | Buy |
2,400,418
+769,700
| +47% | +$55M | 0.02% | 454 |
|
|
2024
Q4 | $73.3M | Buy |
1,630,718
+321,223
| +25% | +$14.4M | 0.01% | 643 |
|
|
2024
Q3 | $66.1M | Buy |
1,309,495
+831,643
| +174% | +$42M | 0.01% | 674 |
|
|
2024
Q2 | $19.5M | Buy |
477,852
+325,232
| +213% | +$13.3M | ﹤0.01% | 967 |
|
|
2024
Q1 | $6.53M | Buy |
+152,620
| New | +$6.53M | ﹤0.01% | 1170 |
|